AIM Rule 26 Disclosures

The following information is being disclosed for the purposes of Rule 26 of the AIM Rules. This information was last updated on 7 March 2012.

  1. Description of the business
  2. Board of directors and biographies
  3. Ethics & responsibilities
  4. Sinclair IS Pharma Operations
  5. Details of any other exchanges or trading platforms: The Company is quoted on the London Stock Exchange's AIM Market (AIM: SPH) and is traded on Euronext Market (SPH)
  6. Number of shares in issue
  7. Major shareholders
  8. Shareholdings and electronic voting
  9. Annual and Interim reports
  10. Press releases
  11. Last change of adviser and Advisers and registrars